Vardenafil (Levitra/Staxyn) Cost in Oklahoma: 2026 Pricing, Insurance, and Savings Guide

What Vardenafil Costs at Oklahoma Pharmacies in 2026

Generic vardenafil tablets average $120 per month across Oklahoma retail pharmacies, based on a typical 8-tablet monthly supply at the 20 mg dose. Brand-name Levitra carries a manufacturer list price near $350 per month from Bayer, though very few pharmacies still stock it since generic vardenafil received FDA approval following patent expiration.

Staxyn (vardenafil ODT), the orally disintegrating formulation, remains brand-only and costs more. Expect $40 to $55 per tablet without insurance at most Oklahoma chains. The ODT form delivers 10 mg vardenafil and should not be substituted interchangeably with the standard tablet, per the FDA-approved prescribing information, because bioavailability differs between formulations.

Pharmacy-to-pharmacy price variation within Oklahoma can be significant. A 2023 JAMA Internal Medicine analysis found that cash prices for the same generic medication varied by as much as 700% across pharmacies within a single metropolitan area. Oklahoma City and Tulsa follow this pattern. Calling two or three pharmacies before filling a prescription is a practical step that can save $50 or more per month.

Costco pharmacies in Oklahoma City and Tulsa tend to offer lower generic pricing than CVS or Walgreens for PDE5 inhibitors, even without a membership for pharmacy purchases (federal law requires this access). Independent pharmacies in smaller Oklahoma cities like Norman, Broken Arrow, and Lawton may also price generics competitively.

Oklahoma Medicaid Does Not Cover Vardenafil

Oklahoma's Medicaid program, SoonerCare, does not cover vardenafil or any other PDE5 inhibitor for erectile dysfunction. This exclusion aligns with a federal provision in the Deficit Reduction Act of 2005 that allows state Medicaid programs to exclude ED drugs from formularies. Most state Medicaid programs have adopted this exclusion.

SoonerCare managed care enrollees face the same restriction. Prior authorization requests for vardenafil for ED indications are routinely denied. The only exception that some state Medicaid programs have considered is pulmonary arterial hypertension (PAH), for which PDE5 inhibitors carry separate FDA indications, but vardenafil specifically lacks an FDA-approved PAH indication (unlike sildenafil and tadalafil).

For Oklahoma Medicaid enrollees who need ED treatment, alternatives include vacuum erection devices (often covered as durable medical equipment) or discussing non-PDE5 options with a provider. Cash-pay generic vardenafil at $10 to $15 per tablet remains the most accessible pharmaceutical option for this population.

Which Oklahoma Insurance Plans Cover Vardenafil

Private insurance coverage for vardenafil in Oklahoma varies by carrier and plan tier. Most employer-sponsored plans that cover ED medications place generic vardenafil on Tier 2 or Tier 3, yielding copays between $25 and $75 for a monthly supply. Brand Levitra, when covered at all, sits on Tier 3 or the specialty tier with copays of $75 to $150.

Blue Cross Blue Shield of Oklahoma covers generic vardenafil on most PPO and HHS plans with quantity limits, typically 8 to 12 tablets per 30-day fill. Step therapy requirements may apply, meaning the plan could require a trial of sildenafil before approving vardenafil. A 2019 study in the Journal of Managed Care & Specialty Pharmacy found that step therapy for PDE5 inhibitors reduced plan spending by 22% but increased patient burden and abandonment rates.

Oklahoma's state employee health plan (HealthChoice) provides limited ED drug coverage. Check the current formulary on the HealthChoice portal, as tier placement and quantity limits change annually.

Medicare Part D plans in Oklahoma generally exclude ED medications following CMS guidance that categorizes them as optional coverage. Some Medicare Advantage plans with enhanced drug benefits do include PDE5 inhibitors, but this is plan-specific. Enrollees should review their plan's formulary or call the plan directly.

Compounded Vardenafil in Oklahoma: Legal Status and Pricing

Compounded vardenafil is legal in Oklahoma through state-licensed 503A compounding pharmacies. These pharmacies operate under FDA regulations in Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding with a valid prescription.

Oklahoma's Board of Pharmacy regulates compounding pharmacies under the Oklahoma Pharmacy Act and requires compliance with USP standards. Both 503A (patient-specific) and 503B (outsourcing facility) compounded products are available in the state, though 503A pharmacies are more common for individual prescriptions.

Compounded vardenafil pricing in Oklahoma typically falls below branded retail costs. Compounding pharmacies may combine vardenafil with other agents (such as tadalafil or sildenafil in combination troches or sublingual formulations) at the direction of a prescriber. These combination products have limited published efficacy data compared to single-agent tablets. The Porst et al. key trial that supported vardenafil's FDA approval evaluated the single agent only at fixed doses of 5, 10, and 20 mg.

Quality control matters. Ask any compounding pharmacy for their most recent third-party potency testing results and verify their PCAB accreditation status if available.

How Vardenafil Compares to Other PDE5 Inhibitors on Cost

Price context helps. In Oklahoma, generic sildenafil (Viagra) averages $15 to $30 per month, making it the cheapest PDE5 inhibitor. Generic tadalafil (Cialis) runs $30 to $90 per month depending on whether it is used on-demand or as a daily 5 mg dose. Generic vardenafil at $120 per month sits at the higher end.

The clinical tradeoff may justify the cost difference for some men. A meta-analysis published in European Urology (2013) found that all three PDE5 inhibitors demonstrated similar overall efficacy rates, but individual response varies. Approximately 30% to 35% of men who fail one PDE5 inhibitor respond to a different one, according to data from switching studies.

Vardenafil's pharmacokinetic profile may suit certain patients better. Its onset of action can be as rapid as 15 minutes in some men, compared to sildenafil's typical 30 to 60 minutes. The Staxyn ODT formulation achieves higher bioavailability than the standard tablet and does not require water, which some patients prefer.

For men who respond well to vardenafil and want to reduce costs, splitting 20 mg tablets (with physician guidance) is a common strategy. The per-milligram cost is often identical across tablet strengths, so buying 20 mg tablets and splitting them effectively halves the price per dose.

Discount Programs and Savings Cards for Oklahoma Residents

Several pathways reduce out-of-pocket vardenafil costs in Oklahoma. GoodRx, RxSaver, and similar aggregator coupons can lower generic vardenafil to $8 to $20 per tablet at participating pharmacies. These prices fluctuate weekly, so comparing across platforms before each fill is worthwhile.

Bayer discontinued the branded Levitra savings card program after generics entered the market. No manufacturer copay card currently exists for generic vardenafil, since multiple generic manufacturers (Teva, Cipla, Lupin, and others) produce it.

Oklahoma-specific programs include:

The Oklahoma Drug Assistance Program does not cover PDE5 inhibitors. Patient assistance foundations like NeedyMeds and RxAssist maintain databases of discount programs, though PDE5 inhibitor coverage through these programs is rare.

Telehealth platforms operating in Oklahoma (Roman, Hims, HealthRX, and others) sometimes bundle vardenafil into subscription pricing that undercuts retail. A monthly subscription may include the consultation fee, prescription, and medication for a flat rate between $30 and $75, depending on the platform and dose.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) uses a transparent cost-plus pricing model and has offered generic vardenafil at prices below typical retail. A 2023 Annals of Internal Medicine analysis found that Cost Plus Drugs priced generics at a median of 47% less than the lowest available price at traditional pharmacies.

Telehealth Prescribing of Vardenafil in Oklahoma

Oklahoma permits telehealth prescribing of vardenafil without restriction. The Oklahoma Telemedicine Act authorizes synchronous audio-video consultations for prescribing controlled and non-controlled medications, and vardenafil is not a controlled substance in Oklahoma or federally.

A telehealth visit for ED evaluation and vardenafil prescribing typically costs $25 to $75 without insurance. Most telehealth platforms accept Oklahoma insurance for the consultation itself, even if the medication requires cash pay.

Oklahoma does not require an in-person visit before a telehealth prescription for vardenafil. The American Urological Association's guidelines on ED management recommend a history and focused physical exam but do not mandate in-person evaluation for straightforward cases. Telehealth providers can assess cardiovascular risk factors, medication interactions (particularly with nitrates, which are absolutely contraindicated), and symptom severity through validated questionnaires like the IIEF-5.

Men with complex medical histories, including unstable angina, recent stroke, or concurrent alpha-blocker therapy, should pursue in-person evaluation per ACC/AHA cardiovascular safety recommendations for PDE5 inhibitor use.

Clinical Efficacy: What the Evidence Shows

Vardenafil's efficacy for ED is well-established across multiple randomized controlled trials. The Porst et al. 2003 study (N=601) demonstrated that vardenafil 20 mg improved erectile function domain scores on the IIEF from a baseline of 13.0 to 22.4, compared to 15.6 with placebo (P<0.001). The 10 mg dose produced similar results, with 80% of intercourse attempts rated successful versus 52% for placebo.

A pooled analysis of four key trials (N=2,431) confirmed response rates of 85% for the 20 mg dose using the GAQ (Global Assessment Questionnaire). Subgroup analyses showed efficacy across age groups, diabetes status, and ED severity, though men with diabetes-related ED showed modestly lower response rates (72% vs. 85% in the non-diabetic population).

The most common adverse effects in trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%). These rates are comparable to other PDE5 inhibitors. Vardenafil carries a specific warning about QTc prolongation at supratherapeutic doses, which distinguishes its safety profile from sildenafil and tadalafil. Men taking Class IA or Class III antiarrhythmics (quinidine, procainamide, amiodarone, sotalol) should avoid vardenafil per FDA labeling.

Standard dosing starts at 10 mg taken 30 to 60 minutes before sexual activity, with adjustment to 5 mg or 20 mg based on response and tolerability. Maximum recommended frequency is once per 24 hours.